GUARINO, DAVIDE MARIA
 Distribuzione geografica
Continente #
NA - Nord America 282
EU - Europa 173
AS - Asia 49
AF - Africa 8
SA - Sud America 1
Totale 513
Nazione #
US - Stati Uniti d'America 280
IT - Italia 76
IE - Irlanda 30
SE - Svezia 29
SG - Singapore 28
CN - Cina 21
UA - Ucraina 10
GB - Regno Unito 8
DE - Germania 5
FR - Francia 5
CI - Costa d'Avorio 4
DK - Danimarca 4
MA - Marocco 4
AT - Austria 3
CA - Canada 2
FI - Finlandia 2
NL - Olanda 1
PE - Perù 1
Totale 513
Città #
Chandler 49
Dublin 30
Des Moines 26
Boardman 25
Fairfield 19
Ashburn 18
Jacksonville 10
Lawrence 10
New York 10
Princeton 10
Houston 9
San Diego 9
Singapore 9
Ancona 7
Turin 7
Cambridge 6
Monte San Vito 5
Shanghai 5
Washington 5
Abidjan 4
Dearborn 4
London 4
Seattle 4
Woodbridge 4
Bologna 3
Conversano 3
Dallas 3
Guangzhou 3
Munich 3
Vienna 3
Wilmington 3
Ann Arbor 2
Arezzo 2
Bari 2
Los Angeles 2
San Benedetto del Tronto 2
San Giorgio di Piano 2
San Mateo 2
Wuhan 2
Andover 1
Beijing 1
Cesano Maderno 1
Cesena 1
Fayetteville 1
Helsinki 1
Hounslow 1
Lima 1
Montréal 1
New Bedfont 1
Pescara 1
Ponte San Pietro 1
Pontevico 1
Santa Clara 1
Secaucus 1
Shenzhen 1
Southwark 1
Toronto 1
Trumbull 1
Wandsworth 1
Yiwu 1
Zibo 1
Totale 348
Nome #
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma 74
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 69
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 67
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma 63
The changing scenario of hepatocellular carcinoma in Italy: an update 39
Monofocal hepatocellular carcinoma: How much does size matter? 38
Pattern of macrovascular invasion in hepatocellular carcinoma 35
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke 33
Surveillance as determinant of long-term survival in non-transplanted hepatocellular carcinoma patients 33
Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization 32
Identification of clinical phenotypes and related survival in patients with large hccs 26
Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection 8
Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative Treatment 8
Models of care in emergency neurology: from the Neuro Fast Track to the emergency neurologist-a position paper of the Italian Association for Emergency Neurology (ANEU) 8
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 5
Totale 538
Categoria #
all - tutte 4.762
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.762


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202013 0 0 0 0 2 2 2 1 2 0 0 4
2020/202138 2 4 4 0 7 1 6 2 4 2 4 2
2021/202259 0 2 2 0 0 1 0 1 2 1 30 20
2022/2023182 11 27 12 13 8 41 0 5 45 0 19 1
2023/2024165 13 4 7 56 15 27 2 4 1 4 18 14
2024/202571 28 25 5 1 12 0 0 0 0 0 0 0
Totale 538